Andrew Alt (University of Michigan) and Robert Damoiseaux (UCLA), Chairs
The mission of the Academic Drug Discovery SIG is to enable greater interaction between academia, pharmaceutical research companies, suppliers and other technical companies. Through a range of unique programs and events, the Academic Drug Discovery SIG will build bridges between the academic and applied sciences. These ties will result in better skilled candidates for the industry as well as enhanced support for academic centers with programs focused on drug discovery, screening, automation, and related disciplines.